Americord Funds Clinical Trial Investigating Umbilical Cord Blood Transplantation In Patients With Hematological Malignancies

NEW YORK, Dec. 1, 2014 /PRNewswire/ -- Americord announced today that it has provided funding to St. Jude's Children's Research Hospital, a research and treatment facility for catastrophic diseases in children, primarily pediatric cancers. A myeloablative preparative regimen, a process of preparing the bodies cells for a transplant, is being researched in the hopes that it will increase the chances that an unrelated stem cell transplant will be accepted by the patient's body.

Logo - http://photos.prnewswire.com/prnh/20141126/161125LOGO

Americord's donation of funds is part of the company's Corporate Giving Program, which was established to support research focused on the therapeutic uses of stem cells from umbilical cord blood, cord tissue, and placenta tissue.

"Americord is committed to supporting the advancement of stem cell technologies that can help treat a range diseases and conditions," said Americord CEO Martin Smithmyer. "We are excited about St. Jude's clinical trial and hopeful that it will lead to advances in the treatment of hematological malignancies."

St. Jude's study began in March 2011 and is anticipated to be complete by June 2020. It is registered with ClinicalTrials.gov in accordance with best practices and requirements of the U.S. Food and Drug Administration.

For more information about the clinical trial: http://1.usa.gov/1tRKpEs

About Americord Registry

Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from the umbilical cord and placenta for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company's laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord Registry's website at www.americordblood.com for more information.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/americord-funds-clinical-trial-investigating-umbilical-cord-blood-transplantation-in-patients-with-hematological-malignancies-300001821.html

SOURCE Americord Registry

Related Links

http://www.americordblood.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED